Company Filing History:
Years Active: 2012-2013
Title: Kazuyuki Nakayama: Innovator in Antibody Fusion Proteins
Introduction
Kazuyuki Nakayama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody fusion proteins. With a total of 2 patents, Nakayama's work is recognized for its potential impact on therapeutic applications.
Latest Patents
His latest patents include innovative technologies such as a polynucleotide encoding an anti-CD14 antibody fusion protein. This invention comprises a protein that includes an anti-CD14 antibody or its active fragment, along with an inhibitor for a protease. Another notable patent is the anti-CD14 antibody fusion protein itself, which similarly combines an anti-CD14 antibody with a protease inhibitor.
Career Highlights
Kazuyuki Nakayama is associated with Mochida Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work focuses on creating effective therapeutic solutions that leverage the unique properties of antibody fusion proteins.
Collaborations
Some of his notable coworkers include Shoji Furusako and Yoshitaka Hosaka, who collaborate with him on various projects within the pharmaceutical industry.
Conclusion
Kazuyuki Nakayama's contributions to the field of biotechnology, particularly through his patents on antibody fusion proteins, highlight his role as an innovator. His work at Mochida Pharmaceutical Co., Ltd. continues to pave the way for advancements in therapeutic applications.